These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34311976)

  • 1. Reply to: Covid-19: Involvement of the nervous system. Identifying neurological predictors defining the course of the disease.
    Mitchell N
    J Neurol Sci; 2021 Sep; 428():117578. PubMed ID: 34311976
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to: Letter to the Editor - N. Mitchell; Covid-19: Involvement of the nervous system. Identifying neurological predictors defining the course of the disease.
    Zifko U; Schmiedlechner T; Saelens J; Zifko K; Wagner M; Assadian O; Grisold W; Stingl H
    J Neurol Sci; 2021 Sep; 428():117577. PubMed ID: 34362575
    [No Abstract]   [Full Text] [Related]  

  • 3. Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside.
    Emmi A; Boura I; Raeder V; Mathew D; Sulzer D; Goldman JE; Leta V
    Int Rev Neurobiol; 2022; 165():17-34. PubMed ID: 36208899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
    Zhou Z; Kang H; Li S; Zhao X
    J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covid-19: Involvement of the nervous system. Identifying neurological predictors defining the course of the disease.
    Zifko U; Schmiedlechner T; Saelens J; Zifko K; Wagner M; Assadian O; Grisold W; Stingl H
    J Neurol Sci; 2021 Jun; 425():117438. PubMed ID: 33857734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercoagulability of COVID-19 and Neurological Complications: A Review.
    Moore P; Esmail F; Qin S; Nand S; Berg S
    J Stroke Cerebrovasc Dis; 2022 Jan; 31(1):106163. PubMed ID: 34763262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to Clear-cut Definitions Is Mandatory When Assessing Short- and Long-term Neurological Complications of COVID-19.
    Finsterer J; A Scorza F
    Intern Med; 2022 Aug; 61(15):2399. PubMed ID: 35022351
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurological infection with SARS-CoV-2 - the story so far.
    Solomon T
    Nat Rev Neurol; 2021 Feb; 17(2):65-66. PubMed ID: 33414554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter to the editor regarding "Coexistence of neurological diseases with Covid-19 pneumonia during the pandemic period".
    Serna-Hernandez JM; Benavides-Guerrero JG; Navarro-Padilla LE; Medina-Sánchez CE; Bolaño-Romero MP
    J Clin Neurosci; 2021 Nov; 93():282-283. PubMed ID: 34362648
    [No Abstract]   [Full Text] [Related]  

  • 10. Are we sure that the neurological impact of COVID 19 in childhood has not been underestimated?
    Principi N; Esposito S
    Ital J Pediatr; 2021 Sep; 47(1):191. PubMed ID: 34537061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of COVID-19 with multiple cranial neuropathies.
    Gogia B; Gil Guevara A; Rai PK; Fang X
    Int J Neurosci; 2022 Dec; 132(12):1187-1189. PubMed ID: 33372575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19's Clinical-Pathological Evidence in Relation to Its Repercussion on the Central and Peripheral Nervous System.
    Morgado AM; Bezerra ALMS; Felix EBG; Júnior JCS; Pinto NB; Neto MLR; de Aguiar Rocha Martin AL
    Adv Exp Med Biol; 2021; 1353():197-215. PubMed ID: 35137375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [COVID-19: A neurological point-of-view].
    Simon OJ; Timmermann L
    Dtsch Med Wochenschr; 2020 Jul; 145(15):1074-1079. PubMed ID: 32731282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply: Neurological disease in pregnant females with COVID-19 may not only be attributable to SARS-CoV-2.
    Magalhães JE; Sampaio-Rocha-Filho PA
    Acta Neurol Scand; 2022 Aug; 146(2):201-202. PubMed ID: 35712940
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to: Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens.
    Teixeira-Vaz A; Paiva JA
    Crit Care Sci; 2023; 35(3):340-341. PubMed ID: 38133169
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to: Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens.
    Teixeira-Vaz A; Paiva JA
    Crit Care Sci; 2023; 35(3):337. PubMed ID: 38133167
    [No Abstract]   [Full Text] [Related]  

  • 17. Emerging neurotropic features of SARS-CoV-2.
    Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
    J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
    Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
    Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies.
    Chong ZZ; Souayah N
    Curr Med Chem; 2022; 29(12):2051-2074. PubMed ID: 33970839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article.
    Taher T; Sheikh AB; Anwar F; Khosa F
    Acta Neurol Belg; 2021 Apr; 121(2):331-339. PubMed ID: 33464546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.